IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets
Allergy · 2025-10 · 80 (10) · 2738-2754
DOI: 10.1111/all.16686 ↗At a glance
Übersichtsarbeit in Allergy, published online on 2025-08-11. Written by Louisa Tedesco and 8 co-authors. Institution: Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia. Major MEDLINE topics: Immunoglobulin G4-Related Disease, Immunoglobulin G, Genetic Variation. Cited 13 times so far (Crossref); 168 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council (NHMRC).
Abstract (original language)
IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses. Its role in immune dysregulation is further underscored by a distinct disease entity called IgG4‐related disease (IgG4‐RD), a systemic fibroinflammatory disorder characterised by IgG4 + plasma cell tissue infiltration, storiform fibrosis and obliterative phlebitis, reflecting a dysregulated immune response affecting multiple organs. This review examines the current understanding of IgG4, its emerging roles in immune dysregulation and IgG4‐RD, including clinical manifestations and treatment options. We also discuss the recent advances in understanding the genetic underpinnings of IgG4‐RD, highlighting the significance of germline gene variants and implicated immune cell types. Finally, we explore future research directions, emphasising the need for deeper insights into pathogenesis, specific biomarkers and optimised treatment strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
- Department of Clinical Immunology and Allergy, Flinders Medical Centre, Bedford Park, South Australia, Australia.
- School of Medicine and Biomedical Sciences, Flinders University, Bedford Park, South Australia, Australia.
- Can Sucak Research Laboratory for Translational Immunology, Hacettepe University, Ankara, Türkiye.
- Institute of Child Health, Hacettepe University, Ankara, Türkiye.
- Faculty of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Istanbul, Türkiye.
ORCID profiles: Louisa Tedesco, Syed B Ali, Baran Erman, Safa Baris, Gökhan Cildir
Funding
- National Health and Medical Research Council (NHMRC)
Cite
APA
Tedesco, L., Ali, S. B., Erman, B., Baris, S., Pant, H., Hissaria, P., Bilginer, Y., Tumes, D. J., & Cildir, G. (2025). IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets. Allergy, 80(10), 2738-2754. https://doi.org/10.1111/all.16686
Vancouver
Tedesco L, Ali SB, Erman B, Baris S, Pant H, Hissaria P, et al. IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets. Allergy. 2025;80(10):2738-2754. doi:10.1111/all.16686
BibTeX
@article{Tedesco2025,
author = {Tedesco, Louisa and Ali, Syed B and Erman, Baran and Baris, Safa and Pant, Harshita and Hissaria, Pravin and Bilginer, Yelda and Tumes, Damon J and Cildir, Gökhan},
title = {IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets},
journal = {Allergy},
year = {2025},
volume = {80},
number = {10},
pages = {2738--2754},
doi = {10.1111/all.16686}
}
EUVIMED